Patents by Inventor Tae Hoon Chun

Tae Hoon Chun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11949153
    Abstract: An electronic device is provided. The electronic device includes an outer housing that comprises a first surface facing a first direction, a second surface facing a second direction opposite to the first direction, and a side surface surrounding a space between the first surface and the second surface, a display adapted to expose at least a portion of the display through the first surface of the outer housing, a PCB arranged between the second surface and the display in an interior of the outer housing, a communication circuit arranged on or over the PCB, a first conductive structure formed of at least one of the first surface or at least a portion of the side surface is electrically connected to the communication circuit, and a second conductive structure formed of the portion of the display electrically connected to the first conductive structure.
    Type: Grant
    Filed: October 14, 2022
    Date of Patent: April 2, 2024
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Tae Young Kim, In Young Lee, Sang Hoon Choi, Woo Suk Kang, Jae Won Choe, Jae Bong Chun
  • Patent number: 11760970
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: September 19, 2023
    Assignee: CJ CHEILJEDANG CORP.
    Inventors: Bong Joon Kim, Heon Woong Jung, Kang Pyo Lee, Sae Hun Kim, Tae Hoon Chun, Kwang Woo Hwang, Tae Joon Won
  • Publication number: 20210054467
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Application
    Filed: October 21, 2020
    Publication date: February 25, 2021
    Applicant: CJ CHEILJEDANG CORP.
    Inventors: Bong Joon KIM, Heon Woong JUNG, Kang Pyo LEE, San Hun KIM, Tae Hoon CHUN, Kwang Woo HWANG, Tae Joon WON
  • Patent number: 10844443
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: November 24, 2020
    Assignee: CJ CHEILJEDANG CORP.
    Inventors: Bong Joon Kim, Heon Woong Jung, Kang Pyo Lee, Sae Hun Kim, Tae Hoon Chun, Kwang Woo Hwang, Tae Joon Won
  • Publication number: 20190062852
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Application
    Filed: August 28, 2018
    Publication date: February 28, 2019
    Applicant: CJ CHEILJEDANG CORP.
    Inventors: Bong Joon Kim, Heon Woong Jung, Kang Pyo Lee, Sae Hun Kim, Tae Hoon Chun, Kwang Woo Hwang, Tae Joon Won
  • Patent number: 10093995
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: October 9, 2018
    Assignee: CJ CHEILJEDANG CORP.
    Inventors: Bong Joon Kim, Heon Woong Jung, Kang Pyo Lee, Sae Hun Kim, Tae Hoon Chun, Kwang Woo Hwang, Tae Joon Won
  • Publication number: 20140011781
    Abstract: Disclosed is a method for treating or preventing anemia. The method includes administering a testis extract serving as an active ingredient for treating or preventing anemia to a mammal. The testis extract is extracted by chloroform and methanol mixed solvent. The testis extract includes nandrolone, testosterone, androstenedione, estradiol, and estrone. The testis extract is prepared by using a method including: adding an extraction solvent to a testis to homogenize; filtering the homogenized mixing solution to remove residues; fractionating a filtrate without the residue to separate a supernatant and a under layer; removing water from the separated under layer; and concentrating an extract without water.
    Type: Application
    Filed: September 17, 2013
    Publication date: January 9, 2014
    Applicant: Industry-Academic Cooperation Foundation, Yeungnam University
    Inventors: In-Ho Choi, Dong-Mok Lee, Eun-Ju Lee, Ki-Ho Lee, Yong-Pil Cheon, Tae-Hoon Chun
  • Publication number: 20130072466
    Abstract: Provided is a composition containing placenta extracts as active ingredients. Placenta extracts are natural substances extracted from placentas of livestock and show effects that can replace steroids and reduce adverse effects of steroids, so that placenta extracts have a wide range of applications including contraceptives, anti-osteoporosis drugs, anti-anemic drugs, therapeutic agents for wasting diseases of muscular atrophy, agents for treating sexual dysfunction, therapeutic agents for wounds, and adipocyte differentiation stimulating agents for improving meat quality of livestock, etc.
    Type: Application
    Filed: February 21, 2011
    Publication date: March 21, 2013
    Applicant: Industry-Academic Cooperation Foundation, Yeungnam University
    Inventors: In Ho Choi, Dong Mok Lee, Eun Ju Lee, Ki-Ho Lee, Yong-Pil Cheon, Tae-Hoon Chun
  • Publication number: 20130018022
    Abstract: The present invention relates to a pharmaceutical composition including a testis extract serving as an active ingredient for treating and preventing anemia, in which since the testis extract induces proliferation of hematopoietic stem cell, an increase in the number of red blood cell, and an increase in the amount of hemoglobin, it is effectively used as a therapeutic agent for treating anemia related to red blood cell and hemoglobin in women of childbearing age, post-childbearing age, and during pregnancy, as well as in men.
    Type: Application
    Filed: April 22, 2010
    Publication date: January 17, 2013
    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YEUNGNAM UNIVERSITY
    Inventors: In-Ho Choi, Dong-Mok Lee, Eun-Ju Lee, Ki-Ho Lee, Yong-Pil Cheon, Tae-Hoon Chun
  • Publication number: 20120208260
    Abstract: Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
    Type: Application
    Filed: October 27, 2010
    Publication date: August 16, 2012
    Applicant: CJ Cheiljedang Corp.
    Inventors: Bong Joon Kim, Heon Woong Jung, Kang Pyo Lee, Sae Hun Kim, Tae Hoon Chun, Kwang Woo Hwang, Tae Joon Won